noom glp 1 reviews before and after I Did the Whole Program. Here's How It Really Went My First Month on GLP-1:

GI symptom rates nearly doubled when participants skipped the titration phase, making the proper retatrutide dose schedule a critical factor in tolerability

This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)

Adjustments based on patient-specific outcomes

Caffrey, M

DOI: 10.1001/jamanetworkopen.2025.35759.

Men typically lose slightly faster in absolute pounds due to higher starting weights and muscle mass